Thoughtful innovations, changing lives.

At PeterBio we apply our breakthrough technologies to develop therapies that change people's lives.

Learn More

At PeterBio we develop innovative gene and cell therapies to help overcome genetic diseases. We focus on treatments that are safe and effective. Our priority is to help as many people as possible.

Our technology

Gene and cell engineering

Our focus is on gene-editing and genome engineering. We have developed a breakthrough gene-editing system that does not require DNA cleavage: Replication Interrupted Template-driven DNA Modification (RITDM™).

Learn more

Our PROGRAMS

Therapeutic focus areas

Our current priority is gene-correction in monogenic diseases. Benefiting from our enhanced safety profile, we not only look at acute life-threatening diseases, but also develop approaches for more chronic diseases that have a strong genetic component, such as Alzheimer’s disease, Sickle Cell Disease and Muscle Dystrophy.

Learn more

News

PRESS
Dirk Hondmann PhD joins PeterBio as CEO
Dirk Hondmann PhD joins PeterBio as CEO...
Read

We use cookies to personalize our service and to improve your experience on the website. We also use thus information for analytics.